መነሻ › የፕሮስቴት ካንሰር › Texas › Dallas
በDallas፣ TX ለየፕሮስቴት ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየፕሮስቴት ካንሰር የሚደረጉ 36 ጥናቶች በDallas እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- UT Southwest Simmons Cancer Center, Dallas
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
DESTINY-PANTUMOUR04
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Research Site, Dallas
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Texas Oncology - DFW ( Site 8001), Dallas
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center - William P. Clements, Jr., University Hospital, Dallas
- University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
- እና 2 ተጨማሪ
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Texas Oncology, Dallas
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mary Crowley Cancer Research, Dallas
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Texas Oncology - DFW (Sammons CC), Dallas
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Texas Southwestern Medical Center, Dallas
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Parkland Health & Hospital System ( Site 0069), Dallas
- UT Southwestern Medical Center ( Site 0039), Dallas
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Urology Clinics of North Texas, Dallas
- University of Texas Southwestern Medical Center, Dallas
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- SCRI at Mary Crowley, Dallas
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Urology Clinics Of North Texas, Dallas
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Texas Southwestern Medical Center, Dallas
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Texas Southwestern Medical Center, Dallas
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Texas Southwestern Medical Center, Dallas
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Dallas VA Medical Center, Dallas
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Urology Clinics of North Texas, Dallas
Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UT Southwestern Medical Center-Dallas, Dallas
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
ተሳታዮችን በመፈለግ ላይደረጃ 3
- UT Southwestern Medical Center, Dallas
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 4
- Univ of Texas Southwest Med Center, Dallas
Outcomes of Focal Ablation for Prostate Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- UTSW, Dallas
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
ተሳታዮችን በመፈለግ ላይደረጃ 3
- UT Southwestern Medical Center, Dallas
Study of AZD0754 in Participants With Metastatic Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Dallas
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mary Crowley Cancer Research, Dallas
- Baylor University Medical Center, Dallas
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Urology Clinics of North Texas, Dallas
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
ተሳታዮችን በመፈለግ ላይደረጃ 4
- UT Southwestern Medical Center, Dallas
Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Ut Southwestern Medical Center, Dallas
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site 120, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Dallas
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Customized TULSA-PRO Ablation Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- University of Texas Southwestern Medical Center, Dallas
በሌሎች ከተሞች ለየፕሮስቴት ካንሰር የሚደረጉ ጥናቶች
- New York City, NY103 ጥናቶች
- Houston, TX76 ጥናቶች
- Los Angeles, CA61 ጥናቶች
- Boston, MA59 ጥናቶች
- St. Louis, MO46 ጥናቶች
- Chicago, IL45 ጥናቶች
- San Francisco, CA45 ጥናቶች
- Philadelphia, PA44 ጥናቶች
- Baltimore, MD43 ጥናቶች
- Nashville, TN42 ጥናቶች
- Seattle, WA42 ጥናቶች
- Washington, DC38 ጥናቶች
በDallas ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር55 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር52 ጥናቶች
- Metastatic Cancer42 ጥናቶች
- የልብ ድካም42 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)37 ጥናቶች
- የኮሎሬክታል ካንሰር33 ጥናቶች
- ከባድ ሰውነት30 ጥናቶች
- የእንቁላል ካንሰር28 ጥናቶች
- የሽንት ፊኛ ካንሰር27 ጥናቶች
- የሳንባ ካንሰር27 ጥናቶች
- የኤንዶሜትሪየም ካንሰር24 ጥናቶች
- የልብና የደም ዝውውር ሕመም23 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።